Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MIRA Pharmaceuticals, Inc. - Common Stock (NQ: MIRA )

1.930 +0.050 (+2.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 535,781
Open 1.930
Bid (Size) 1.860 (4)
Ask (Size) 1.880 (1)
Prev. Close 1.880
Today's Range 1.750 - 1.930
52wk Range 0.5100 - 6.835
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024
MIRA stock results show that Mira Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor
Via ACCESSWIRE

Performance

YTD
+62.18%
+62.18%
1 Month
+135.34%
+135.34%
3 Month
+194.66%
+194.66%
6 Month
+85.58%
+85.58%
1 Year
-70.31%
-70.31%

More News

Read More
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
Via Benzinga
(MIRA) - Analyzing Mira Pharmaceuticals's Short Interest
Via Benzinga
MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action
Via ACCESSWIRE
MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year
Via News Direct
Topics Cannabis
Exposures Cannabis
Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data
Via Benzinga
Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
Via ACCESSWIRE
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
Via ACCESSWIRE
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?
Via InvestorPlace
Dow Edges Lower; Verizon Shares Fall After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Nano-Cap MIRA Pharmaceuticals' Oral Ketamine Analog Shows Potential In Neuropsychiatric Disorders
Via Benzinga
Nasdaq Gains 1%; Chicago Fed National Activity Falls In June
Via Benzinga
Topics Economy
Exposures Interest Rates
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Mira Pharmaceuticals Stock Is Moving Higher Monday
Via Benzinga
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.